Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Startups Marketing Prescription Drugs Should Tread Carefully
Private Equity

Startups Marketing Prescription Drugs Should Tread Carefully

by fortune.com posted 1month ago 12 views
On deals and dealmakers. : Ro, a direct-to-consumer telehealth business, is raising another round of funding. According to TechCrunch, the company is raising $85 million in Series B funding at a $500 million valuation. It’s unclear who participated in the latest financing, but Ro’s prior investors include FirstMark Capital, SignalFire, Initialized Capital, General Catalyst, Slow Ventures, Sinai Ventures, Torch Capital, BoxGroup, and Tusk Ventures. You may remember that I wrote about Ro’s last $88 million fundraise just seven months ago. At that point in time, the startup had been marketing itself as a men’s wellness/erectile dysfunction business.